Evidence map›Paper›PMID 20547083›Full record

ArticleMolecular genetics and metabolism2010

Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening.

Jaffar Alfardan, Al-Walid Mohsen, Sara Copeland, Jay Ellison, Laura Keppen-Davis, Marianne Rohrbach, Berkley R Powell, Jane Gillis, Dietrich Matern, Jeffrey Kant and 1 more

Open access · greenAbstract read
In one paragraph

Article in Molecular genetics and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Laboratory analysis of organic acids, 2018 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Aspects of Newborn Screening in Isovaleric Acidemia.International journal of neonatal screening · 2018
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 4 countries.

Jaffar AlfardanKing Fahad Specialist Hospital-Dammam, Saudi Arabia.
Al-Walid Mohsen
Sara Copeland
Jay Ellison
Laura Keppen-Davis
Marianne Rohrbach
Berkley R Powell
Jane Gillis
Dietrich Matern
Jeffrey Kant
Jerry Vockley
University of Pittsburgh · USMayo Clinic in Arizona · USChildren's Hospital Central California · USHospital for Sick Children · CAIzaak Walton Killam Health Centre · CAKing Fahad Specialist Hospital · SAUniversity of Iowa Stead Family Children’s Hospital · USUniversity of South Dakota · US

Funding

METABOLISM OF SHORT CHAIN ACYL COAS AND THEIR DEFICIENCYR01DK054936 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VOCKLEY, GERARD · 1999 to 2013
$2.5M
NIDDK NIH HHS R01 DK054936NIDDK NIH HHS R01 DK54936
6 · The paper itself

Abstract

Short/branched chain acyl-CoA dehydrogenase (SBCAD) deficiency, also known as 2-methylbutyryl-CoA dehydrogenase deficiency, is a recently described autosomal recessive disorder of isoleucine metabolism. Most patients reported thus far have originated from a founder mutation in the Hmong Chinese population. While the first reported patients had severe disease, most of the affected Hmong have remained asymptomatic. In this study, we describe 11 asymptomatic non-Hmong patients brought to medical attention by elevated C5-carnitine found by newborn screening and one discovered because of clinical symptoms. The diagnosis of SBCAD deficiency was determined by metabolite analysis of blood, urine, and fibroblast samples. PCR and bidirectional sequencing were performed on genomic DNA from five of the patients covering the entire SBCAD (ACADSB) gene sequence of 11 exons. Sequence analysis of genomic DNA from each patient identified variations in the SBCAD gene not previously reported. Escherichia coli expression studies revealed that the missense mutations identified lead to inactivation or instability of the mutant SBCAD enzymes. These findings confirm that SBCAD deficiency can be identified through newborn screening by acylcarnitine analysis. Our patients have been well without treatment and call for careful follow-up studies to learn the true clinical impact of this disorder.

Indexed as

Neonatal ScreeningAmino Acid Metabolism, Inborn ErrorsBase SequenceCell LineComputational BiologyDNA Mutational AnalysisElectrophoresis, Polyacrylamide GelHumansInfant, NewbornMutant ProteinsMutationOxidoreductases Acting on CH-CH Group DonorsProtein Structure, Secondary2-methylacyl-CoA dehydrogenaseMutant ProteinsOxidoreductases Acting on CH-CH Group Donors

Identifiers

PMID20547083
PMCPMC2906669
OpenAlexW1965742056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.